Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states: A doubling of treatment rates over the course of 5 years

Stroke

Volumn 42, Issue 7, 2011, Pages 1952-1955

  Adeoye, Opeolu ^a   Hornung, Richard ^a   Khatri, Pooja ^a,b   Kleindorfer, Dawn ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

acute stroke; thrombolysis

Indexed keywords

ALTEPLASE;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DIAGNOSIS RELATED GROUP; DRUG EFFICACY; DRUG UTILIZATION; FIBRINOLYTIC THERAPY; HOSPITAL BILLING; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT RESPONSE; UNITED STATES;

AGED; BRAIN ISCHEMIA; DATA INTERPRETATION, STATISTICAL; HEALTH CARE COSTS; HUMANS; INSURANCE CLAIM REVIEW; MEDICARE; MIDDLE AGED; PHARMACY; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 79959981013     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.612358     Document Type: Article

References (7)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-1587.
2. Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004;35:e27-e29.
3. Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM, et al. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004;61:346-350. (Pubitemid 38327350)
4. Qureshi AI, Suri MF, Nasar A, He W, Kirmani JF, Divani AA, et al. Thrombolysis for ischemic stroke in the united states: Data from national hospital discharge survey 1999-2001. Neurosurgery. 2005;57:647-654; discussion 647-654.
5. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64:654-659.
6. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008;39:924-928. (Pubitemid 351619542)
7. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 update. A report from the American Heart Association. Circulation. 2010;121:948-954